It is also demonstrated that tumor TGF-β induces CD39/CD73 over-expression on MDSCs in NSCLC TME via phosphorylation of mTOR, and subsequently activation of hypoxia-inducible factor-1 (HIF-1) signaling. This evidence concerns the gene ENTPD1 and neoplasm.